Eli Lilly & Co.’s first-quarter earnings rose...

Eli Lilly & Co.’s first-quarter earnings rose 13.6% to $233.2 million from $205.2 million a year ago, the Indianapolis-based pharmaceuticals company said. The firm said its sales rose to $1.07 billion from $967.2 million. Lilly said its worldwide pharmaceutical sales increased, led by Ceclor, an oral antibiotic, and Humulin, a human insulin.